Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients
NCT03385031
·
clinicaltrials.gov ↗
COMPLETED
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
OTHER:
CBCT imaging
Sponsor
Maastricht Radiation Oncology